A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Clinical trial NCT05981846 · COMPLETED

Trial details

NCT number: NCT05981846
Sponsor: Hipra Scientific, S.L.U
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS CoV 2 Infection Influenza, Human

Start date: 2023-09-04
Primary completion: 2023-10-09
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.